Partnership8 Sept 2025, 06:32 pm
Strides Pharma Science Ltd Enters Strategic Partnership with Kenox to Expand Nasal Spray Portfolio for US Market
AI Summary
Strides Pharma Science Ltd, a global pharmaceutical company, has entered into a strategic product development partnership with Kenox Pharmaceuticals Inc. The partnership aims to expand Strides' nasal spray portfolio for the US market across diverse therapeutic areas. Kenox will provide formulation and development expertise in Orally Inhaled and Nasal Drug Products (OINDPs). The collaboration aims to accelerate affordable, high-quality medicines for patients in the US. Specific product details remain confidential at this stage.
Key Highlights
- Strides Pharma Science Ltd enters into a strategic product development partnership with Kenox Pharmaceuticals Inc.
- The partnership aims to expand Strides' nasal spray portfolio for the US market across diverse therapeutic areas.
- Kenox will provide formulation and development expertise in Orally Inhaled and Nasal Drug Products (OINDPs).
- The collaboration aims to accelerate affordable, high-quality medicines for patients in the US.
- The partnership advances a pipeline of nasal spray products for the US market, combining Strides’ commercial strengths with Kenox’s OINDP expertise.